HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan.

Abstract
A 14-year-old Saudi boy with cherry red spot-myoclonus syndrome and documented neuraminidase deficiency responded well to titrated doses of 5-hydroxytryptophan as an add-on treatment.
AuthorsG Gascon, B Wallenberg, A K Daif, P Ozand
JournalAnnals of neurology (Ann Neurol) Vol. 24 Issue 3 Pg. 453-5 (Sep 1988) ISSN: 0364-5134 [Print] United States
PMID3265864 (Publication Type: Case Reports, Journal Article)
Chemical References
  • 5-Hydroxytryptophan
  • Neuraminidase
Topics
  • 5-Hydroxytryptophan (therapeutic use)
  • Adolescent
  • Female
  • Humans
  • Male
  • Myoclonus (drug therapy, etiology, genetics)
  • Neuraminidase (deficiency)
  • Pedigree
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: